U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07465757) titled 'A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC)' on March 06.
Brief Summary: The goal of this clinical trial is to determine how well people tolerate treatment with alisertib at different doses when it is used together with paclitaxel to treat people with SCLC. The main question it aims to answer is:
* What percentage of side effects, both mild and serious, do participants experience when being treated with alisertib and paclitaxel based on the National Cancer Institute Common Terminology Criteria for Adverse Events version 5.0 (NCI CTCAE v.5.0)?
The study will consist of different groups, calle...